Organization

Zhongmou Therapeutics

2 clinical trials

Clinical trial

Prospective, Dose-Escalating, Investigator Initiated Trial to Evaluate the Safety and Efficacy of ZM-02 in Retinitis Pigmentosa

Status: Not yet recruiting, Estimated PCD: 2027-12-25

Clinical trial

Prospective, Dose-Escalating, Investigator Initiated Trial to Evaluate the Safety and Efficacy of ZM-01 in 3-18 Year-old Male Subjects With X-linked Retinoschisis

Status: Recruiting, Estimated PCD: 2023-10-31